This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Asc Therapeutics Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations in Gene Editing by Mi Shi
Introduction
Mi Shi is an accomplished inventor based in Milpitas, California. He has made significant contributions to the field of gene editing, particularly through his innovative methods that utilize viruses for genetic modifications. His work is pivotal in advancing genetic research and therapeutic applications.
Latest Patents
Mi Shi holds a patent for a gene editing method that employs a virus to insert a polynucleotide sequence into the genome of a cell. This method involves generating a double-strand break at a target site within the genome and introducing a virus that carries the nucleic acid sequence intended for insertion. Notably, the nucleic acid does not require homologous arms or may include very short homologous arms corresponding to the target site. This innovative approach enhances the efficiency of gene editing techniques.
Career Highlights
Mi Shi is currently associated with Asc Therapeutics Inc., where he continues to develop groundbreaking technologies in gene editing. His expertise and innovative mindset have positioned him as a key player in the biotechnology sector.
Collaborations
Mi Shi collaborates with talented individuals such as Ling-Jie Kong and Hainan Chen, who contribute to the advancement of their shared goals in genetic research and development.
Conclusion
Mi Shi's contributions to gene editing through his innovative methods and collaborations highlight the importance of research in biotechnology. His work continues to pave the way for future advancements in genetic therapies.